Literature DB >> 14685664

Lactic acidosis: an early marker of propofol infusion syndrome?

Marc Koch, Daniel De Backer, Jean-Louis Vincent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14685664     DOI： 10.1007/s00134-003-2130-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Lactic acidosis.

Authors:  Daniel De Backer
Journal:  Intensive Care Med       Date:  2003-04-08       Impact factor: 17.440

2.  Impaired fatty acid oxidation in propofol infusion syndrome.

Authors:  A Wolf; P Weir; P Segar; J Stone; J Shield
Journal:  Lancet       Date:  2001-02-24       Impact factor: 79.321

3.  Lactic acidosis associated with propofol.

Authors:  M A Marinella
Journal:  Chest       Date:  1996-01       Impact factor: 9.410

Review 4.  Lactic acidemia and bradyarrhythmia in a child sedated with propofol.

Authors:  S H Cray; B H Robinson; P N Cox
Journal:  Crit Care Med       Date:  1998-12       Impact factor: 7.598

Review 5.  The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome.

Authors:  Beatrice Vasile; Frank Rasulo; Andrea Candiani; Nicola Latronico
Journal:  Intensive Care Med       Date:  2003-08-06       Impact factor: 17.440
  5 in total
  12 in total

1.  [Propofol infusion syndrome].

Authors:  E Trampitsch; M Oher; I Pointner; R Likar; R Jost; H V Schalk
Journal:  Anaesthesist       Date:  2006-11       Impact factor: 1.041

Review 2.  Drug-induced acid-base disorders.

Authors:  Daniel Kitterer; Matthias Schwab; M Dominik Alscher; Niko Braun; Joerg Latus
Journal:  Pediatr Nephrol       Date:  2014-11-05       Impact factor: 3.714

3.  Propofol Infusion syndrome during refractory status epilepticus in a young adult: successful ECMO resuscitation.

Authors:  Christophe Guitton; Laurence Gabillet; Patrick Latour; Jean-Christophe Rigal; David Boutoille; Ousama Al Habash; Pascal Derkinderen; Cédric Bretonniere; Daniel Villers
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

4.  Lactate-to-pyruvate ratio as a marker of propofol infusion syndrome after subarachnoid hemorrhage.

Authors:  Jared M Pisapia; Linda C Wendell; Monisha A Kumar; Eric L Zager; Joshua M Levine
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

5.  Role of mitochondrial complex I and protective effect of CoQ10 supplementation in propofol induced cytotoxicity.

Authors:  Christian Bergamini; Noah Moruzzi; Francesco Volta; Laura Faccioli; Jantje Gerdes; Maria Cristina Mondardini; Romana Fato
Journal:  J Bioenerg Biomembr       Date:  2016-08-15       Impact factor: 2.945

6.  [Long-term therapy with propofol has no impact on microcirculation in medical intensive care patients].

Authors:  Christian Jung; Christoph Rödiger; Alexander Lauten; Michael Fritzenwanger; Bjoern Goebel; Julia Schumm; Hans-Reiner Figulla; Markus Ferrari
Journal:  Med Klin (Munich)       Date:  2009-05-16

Review 7.  [Propofol infusion syndrome].

Authors:  J Motsch; J Roggenbach
Journal:  Anaesthesist       Date:  2004-10       Impact factor: 1.041

8.  Undiagnosed catecholamine-secreting paraganglioma and coexisting carcinoid in a patient with MH susceptibility: an unusual anesthetic challenge.

Authors:  Jana Hudcova; Roman Schumann
Journal:  J Anesth       Date:  2007-01-30       Impact factor: 2.078

9.  Hyperkalemia during surgery: is it an early warning of propofol infusion syndrome?

Authors:  Ashish R Mali; Vijaya P Patil; C S Pramesh; Rajesh C Mistry
Journal:  J Anesth       Date:  2009-08-14       Impact factor: 2.078

10.  Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study.

Authors:  Russel J Roberts; Jeffrey F Barletta; Jeffrey J Fong; Greg Schumaker; Philip J Kuper; Stella Papadopoulos; Dinesh Yogaratnam; Elise Kendall; Renee Xamplas; Anthony T Gerlach; Paul M Szumita; Kevin E Anger; Paul A Arpino; Stacey A Voils; Philip Grgurich; Robin Ruthazer; John W Devlin
Journal:  Crit Care       Date:  2009-10-29       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.